Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-006666

Chief Legal Officer gave up 1,318 shares (to pay taxes)

  • Chief Legal Officer acquired 3,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-03 Exercise or conversion : show line 1 in the form +3,875 88,121 D
2020-02-03 Shares withheld for taxes : show line 2 in the form −1,318 $1.28 $1,687 86,803 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,875 7,750 D
Loading xslF345X03/doc4.xml…